Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer trials recruiting in Missouri

Fewer than 3 recruiting trials found.

All Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer trials nationally

1

Recruiting in Missouri

1

Cities with sites

Cities in Missouri

St Louis 1

Recruiting trials in Missouri

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT06374459 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.